{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:43:46Z","timestamp":1787748226343,"version":"build-2784847793"},"reference-count":99,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n-FEDER","doi-asserted-by":"crossref","award":["SAF2007-61769"],"award-info":[{"award-number":["SAF2007-61769"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n-FEDER","doi-asserted-by":"crossref","award":["RETICEF RD06\/0013\/2001"],"award-info":[{"award-number":["RETICEF RD06\/0013\/2001"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.bcp.2010.02.017","type":"journal-article","created":{"date-parts":[[2010,3,4]],"date-time":"2010-03-04T09:41:00Z","timestamp":1267695660000},"page":"13-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":113,"title":["New molecular targets for the treatment of osteoarthritis"],"prefix":"10.1016","volume":"80","author":[{"given":"Maria Jos\u00e9","family":"Alcaraz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Meg\u00edas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Garc\u00eda-Arnandis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Cl\u00e9rigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Isabel","family":"Guill\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2010.02.017_bib1","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/jcp.21258","article-title":"Osteoarthritis","volume":"213","author":"Goldring","year":"2007","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.bcp.2010.02.017_bib2","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/ar2592","article-title":"Cartilage homeostasis in health and rheumatic diseases","volume":"11","author":"Goldring","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.bcp.2010.02.017_bib3","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.joca.2005.10.011","article-title":"A review of the effects of insulin-like growth factor and platelet derived growth factor on in vivo cartilage healing and repair","volume":"14","author":"Schmidt","year":"2006","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.bcp.2010.02.017_bib4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/art.1780370215","article-title":"Human osteoarthritic chondrocytes possess an increased number of insulin-like growth factor 1 binding sites but are unresponsive to its stimulation. Possible role of IGF-1-binding proteins","volume":"37","author":"Dore","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bcp.2010.02.017_bib5","doi-asserted-by":"crossref","first-page":"R177","DOI":"10.1186\/ar2087","article-title":"Abnormal insulin-like growth factor 1 signaling in human osteoarthritic subchondral bone osteoblasts","volume":"8","author":"Massicotte","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.bcp.2010.02.017_bib6","doi-asserted-by":"crossref","first-page":"R393","DOI":"10.1186\/ar1201","article-title":"Pharmacological disruption of insulin-like growth factor 1 binding to IGF-binding proteins restores anabolic responses in human osteoarthritic chondrocytes","volume":"6","author":"De Ceuninck","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.bcp.2010.02.017_bib7","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.orthres.2004.06.020","article-title":"Dual transduction of insulin-like growth factor-I and interleukin-1 receptor antagonist protein controls cartilage degradation in an osteoarthritic culture model","volume":"23","author":"Haupt","year":"2005","journal-title":"J Orthop Res"},{"key":"10.1016\/j.bcp.2010.02.017_bib8","first-page":"1565","article-title":"Prolonged treatment of human osteoarthritic chondrocytes with insulin-like growth factor-I stimulates proteoglycan synthesis but not proteoglycan matrix accumulation in alginate cultures","volume":"30","author":"Loeser","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.bcp.2010.02.017_bib9","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1002\/art.11209","article-title":"The combination of insulin-like growth factor 1 and osteogenic protein 1 promotes increased survival of and matrix synthesis by normal and osteoarthritic human articular chondrocytes","volume":"48","author":"Loeser","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bcp.2010.02.017_bib10","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/art.21756","article-title":"Are bone morphogenetic proteins effective inducers of cartilage repair? Ex vivo transduction of muscle-derived stem cells","volume":"54","author":"Goldring","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bcp.2010.02.017_bib11","doi-asserted-by":"crossref","first-page":"16502","DOI":"10.1074\/jbc.M512494200","article-title":"Bone morphogenetic protein-2 stimulates Runx2 acetylation","volume":"281","author":"Jeon","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2010.02.017_bib12","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1002\/art.20441","article-title":"Differential gene expression and regulation of the bone morphogenetic protein antagonists follistatin and gremlin in normal and osteoarthritic human chondrocytes and synovial fibroblasts","volume":"50","author":"Tardif","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bcp.2010.02.017_bib13","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1517\/14712590902936823","article-title":"TGF-beta3: A potential biological therapy for enhancing chondrogenesis","volume":"9","author":"Tang","year":"2009","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.bcp.2010.02.017_bib14","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1136\/ard.2005.045971","article-title":"Expression of transforming growth factor-beta (TGFbeta) and the TGFbeta signalling molecule Smad-2P in spontaneous and instability-induced osteoarthritis: role in cartilage degradation, chondrogenesis and osteophyte formation","volume":"65","author":"Blaney Davidson","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.bcp.2010.02.017_bib15","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1186\/ar1931","article-title":"TGF beta-induced cartilage repair is maintained but fibrosis is blocked in the presence of Smad7","volume":"8","author":"Blaney Davidson","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.bcp.2010.02.017_bib16","doi-asserted-by":"crossref","first-page":"31409","DOI":"10.1074\/jbc.M706508200","article-title":"Basic fibroblast growth factor activates the MAPK and NFkappaB pathways that converge on Elk-1 to control production of matrix metalloproteinase-13 by human adult articular chondrocytes","volume":"282","author":"Muddasani","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2010.02.017_bib17","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1517\/14712590903246370","article-title":"Stem cell therapy for cartilage regeneration in osteoarthritis","volume":"9","author":"Koelling","year":"2009","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.bcp.2010.02.017_bib18","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.bbrc.2004.10.055","article-title":"Cartilage-derived morphogenetic protein-1 promotes the differentiation of mesenchymal stem cells into chondrocytes","volume":"325","author":"Bai","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bcp.2010.02.017_bib19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/art.24153","article-title":"Blocking vascular endothelial growth factor with soluble Flt-1 improves the chondrogenic potential of mouse skeletal muscle-derived stem cells","volume":"60","author":"Kubo","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bcp.2010.02.017_bib20","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/art.24443","article-title":"Cartilage repair in a rat model of osteoarthritis through intraarticular transplantation of muscle-derived stem cells expressing bone morphogenetic protein 4 and soluble Flt-1","volume":"60","author":"Matsumoto","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bcp.2010.02.017_bib21","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/jor.20516","article-title":"Programmable cells of monocytic origin (PCMO): a source of peripheral blood stem cells that generate collagen type II-producing chondrocytes","volume":"26","author":"Pufe","year":"2008","journal-title":"J Orthop Res"},{"key":"10.1016\/j.bcp.2010.02.017_bib22","doi-asserted-by":"crossref","unstructured":"Li X, Wu JF. Recent developments in patent anti-cancer agents targeting the matrix metalloproteinases (MMPs). Recent Pat Anticancer Drug Discov 2009 [Epub ahead of print].","DOI":"10.2174\/157489210790936234"},{"key":"10.1016\/j.bcp.2010.02.017_bib23","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1002\/art.25002","article-title":"Matrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development","volume":"60","author":"Little","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bcp.2010.02.017_bib24","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1110\/ps.073130208","article-title":"Characterization of an exosite binding inhibitor of matrix metalloproteinase 13","volume":"17","author":"Gooljarsingh","year":"2008","journal-title":"Protein Sci"},{"key":"10.1016\/j.bcp.2010.02.017_bib25","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1021\/jm801394m","article-title":"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13","volume":"52","author":"Monovich","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.bcp.2010.02.017_bib26","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1002\/art.24629","article-title":"A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models","volume":"60","author":"Baragi","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bcp.2010.02.017_bib27","doi-asserted-by":"crossref","first-page":"27781","DOI":"10.1074\/jbc.M703286200","article-title":"Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects","volume":"282","author":"Johnson","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2010.02.017_bib28","doi-asserted-by":"crossref","first-page":"12501","DOI":"10.1074\/jbc.C000848200","article-title":"TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5)","volume":"276","author":"Kashiwagi","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2010.02.017_bib29","doi-asserted-by":"crossref","first-page":"8592","DOI":"10.1074\/jbc.M308708200","article-title":"Differential inhibition of membrane type 3 (MT3)-matrix metalloproteinase (MMP) and MT1-MMP by tissue inhibitor of metalloproteinase (TIMP)-2 and TIMP-3 regulates pro-MMP-2 activation","volume":"279","author":"Zhao","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2010.02.017_bib30","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/art.22427","article-title":"Increased collagen and aggrecan degradation with age in the joints of Timp3(-\/-) mice","volume":"56","author":"Sahebjam","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bcp.2010.02.017_bib31","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/ncprheum0841","article-title":"Drug insight: aggrecanases as therapeutic targets for osteoarthritis","volume":"4","author":"Fosang","year":"2008","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.bcp.2010.02.017_bib32","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.joca.2008.09.018","article-title":"ADAMTS5-\/- mice have less subchondral bone changes after induction of osteoarthritis through surgical instability: implications for a link between cartilage and subchondral bone changes","volume":"17","author":"Botter","year":"2009","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.bcp.2010.02.017_bib33","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.bmcl.2006.12.020","article-title":"5-((1H-pyrazol-4-yl)methylene)-2-thioxothiazolidin-4-one inhibitors of ADAMTS-5","volume":"17","author":"Gilbert","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bcp.2010.02.017_bib34","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.bmcl.2006.12.027","article-title":"Synthesis and evaluation of aryl thioxothiazolidinone inhibitors of ADAMTS-5 (Aggrecanase-2)","volume":"17","author":"Bursavich","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bcp.2010.02.017_bib35","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.1016\/j.bmcl.2007.07.048","article-title":"5\u2032-Phenyl-3\u2032H-spiro[indoline-3,2\u2032-[1,3,4]thiadiazol]-2-one inhibitors of ADAMTS-5 (aggrecanase-2)","volume":"17","author":"Bursavich","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bcp.2010.02.017_bib36","doi-asserted-by":"crossref","first-page":"6454","DOI":"10.1016\/j.bmcl.2008.10.065","article-title":"N-((8-hydroxy-5-substituted-quinolin-7-yl)(phenyl)methyl)-2-phenyloxy\/amino-acetamide inhibitors of ADAMTS-5 (Aggrecanase-2)","volume":"18","author":"Gilbert","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bcp.2010.02.017_bib37","doi-asserted-by":"crossref","first-page":"6393","DOI":"10.1021\/bi7000642","article-title":"Substrate-dependent inhibition kinetics of an active site-directed inhibitor of ADAMTS-4 (Aggrecanase 1)","volume":"46","author":"Wittwer","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2010.02.017_bib38","doi-asserted-by":"crossref","first-page":"24185","DOI":"10.1074\/jbc.M109.029116","article-title":"Structural and inhibition analysis reveals the mechanism of selectivity of a series of aggrecanase inhibitors","volume":"284","author":"Tortorella","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2010.02.017_bib39","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1096\/fj.08-112680","article-title":"Calcium pentosan polysulfate is a multifaceted exosite inhibitor of aggrecanases","volume":"22","author":"Troeberg","year":"2008","journal-title":"FASEB J"},{"key":"10.1016\/j.bcp.2010.02.017_bib40","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/ng1496","article-title":"An aspartic acid repeat polymorphism in asporin inhibits chondrogenesis and increases susceptibility to osteoarthritis","volume":"37","author":"Kizawa","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.bcp.2010.02.017_bib41","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/s00776-009-1401-4","article-title":"Asporin and transforming growth factor-beta gene expression in osteoblasts from subchondral bone and osteophytes in osteoarthritis","volume":"14","author":"Sakao","year":"2009","journal-title":"J Orthop Sci"},{"key":"10.1016\/j.bcp.2010.02.017_bib42","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1016-8478(23)07324-7","article-title":"Molecular and cellular mechanisms of syndecans in tissue injury and inflammation","volume":"24","author":"Bartlett","year":"2007","journal-title":"Mol Cells"},{"key":"10.1016\/j.bcp.2010.02.017_bib43","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/nm.1998","article-title":"Syndecan-4 regulates ADAMTS-5 activation and cartilage breakdown in osteoarthritis","volume":"15","author":"Echtermeyer","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.bcp.2010.02.017_bib44","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/path.2529","article-title":"Discoidin domain receptor 2 mediates the collagen II-dependent release of interleukin-6 in primary human chondrocytes","volume":"218","author":"Klatt","year":"2009","journal-title":"J Pathol"},{"key":"10.1016\/j.bcp.2010.02.017_bib45","doi-asserted-by":"crossref","first-page":"R121","DOI":"10.1186\/ar2329","article-title":"Activation of proteinase-activated receptor 2 in human osteoarthritic cartilage upregulates catabolic and proinflammatory pathways capable of inducing cartilage degradation: a basic science study","volume":"9","author":"Boileau","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.bcp.2010.02.017_bib46","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bone.2009.02.015","article-title":"Proteinase-activated receptor (PAR)-2 activation impacts bone resorptive properties of human osteoarthritic subchondral bone osteoblasts","volume":"44","author":"Amiable","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.bcp.2010.02.017_bib47","first-page":"237","article-title":"The role of cytokines in osteoarthritis pathophysiology","volume":"39","author":"Fernandes","year":"2003","journal-title":"Biorheology"},{"key":"10.1016\/j.bcp.2010.02.017_bib48","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S1063-4584(03)00153-5","article-title":"Pralnacasan, an inhibitor of interleukin-1beta converting enzyme, reduces joint damage in two murine models of osteoarthritis","volume":"11","author":"Rudolphi","year":"2003","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.bcp.2010.02.017_bib49","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/art.1780390914","article-title":"Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis. Suppression of collagenase-1 expression","volume":"39","author":"Caron","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bcp.2010.02.017_bib50","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/sj.gt.3302196","article-title":"Osteoarthritis gene therapy","volume":"11","author":"Evans","year":"2004","journal-title":"Gene Ther"},{"key":"10.1016\/j.bcp.2010.02.017_bib51","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2165\/00063030-200519060-00003","article-title":"Novel biological approaches to the intra-articular treatment of osteoarthritis","volume":"19","author":"Evans","year":"2005","journal-title":"BioDrugs"},{"key":"10.1016\/j.bcp.2010.02.017_bib52","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2302\/kjm.58.29","article-title":"New perspective in osteoarthritis: the OPG and RANKL system as a potential therapeutic target?","volume":"58","author":"Tat","year":"2009","journal-title":"Keio J Med"},{"key":"10.1016\/j.bcp.2010.02.017_bib53","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1002\/art.22941","article-title":"Prevention of cartilage destruction with intraarticular osteoclastogenesis inhibitory factor\/osteoprotegerin in a murine model of osteoarthritis","volume":"56","author":"Shimizu","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bcp.2010.02.017_bib54","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/rheumatology\/kep300","article-title":"Modulation of OPG. RANK and RANKL by human chondrocytes and their implication during osteoarthritis","volume":"48","author":"Kwan","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.bcp.2010.02.017_bib55","doi-asserted-by":"crossref","first-page":"3820","DOI":"10.1002\/art.24029","article-title":"Activation of the receptor EphB4 by its specific ligand ephrin B2 in human osteoarthritic subchondral bone osteoblasts","volume":"58","author":"Kwan","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bcp.2010.02.017_bib56","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.joca.2007.11.006","article-title":"Intra-articular injection of interleukin-4 decreases nitric oxide production by chondrocytes and ameliorates subsequent destruction of cartilage in instability-induced osteoarthritis in rat knee joints","volume":"16","author":"Yorimitsu","year":"2008","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.bcp.2010.02.017_bib57","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/jcb.21434","article-title":"Interleukin-4 antagonizes oncostatin M and transforming growth factor beta-induced responses in articular chondrocytes","volume":"103","author":"El Mabrouk","year":"2008","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.bcp.2010.02.017_bib58","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1002\/art.11338","article-title":"Increased oxidative stress with aging reduces chondrocyte survival: correlation with intracellular glutathione levels","volume":"48","author":"Carlo","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bcp.2010.02.017_bib59","doi-asserted-by":"crossref","first-page":"C961","DOI":"10.1152\/ajpcell.2000.279.4.C961","article-title":"Nitric oxide inhibits chondrocyte response to IGF-I: inhibition of IGF-IRbeta tyrosine phosphorylation","volume":"279","author":"Studer","year":"2000","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.bcp.2010.02.017_bib60","doi-asserted-by":"crossref","first-page":"9132","DOI":"10.1074\/jbc.M804178200","article-title":"Effects of hyaluronic acid on mitochondrial function and mitochondria-driven apoptosis following oxidative stress in human chondrocytes","volume":"284","author":"Grishko","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2010.02.017_bib61","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1002\/art.22174","article-title":"Large-scale gene expression profiling reveals major pathogenetic pathways of cartilage degeneration in osteoarthritis","volume":"54","author":"Aigner","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bcp.2010.02.017_bib62","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0014-5793(02)03511-1","article-title":"Expression and regulation of peroxiredoxin 5 in human osteoarthritis","volume":"531","author":"Wang","year":"2002","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bcp.2010.02.017_bib63","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1002\/art.22917","article-title":"Water-soluble C60 fullerene prevents degeneration of articular cartilage in osteoarthritis via down-regulation of chondrocyte catabolic activity and inhibition of cartilage degeneration during disease development","volume":"56","author":"Yudoh","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bcp.2010.02.017_bib64","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/ki.1997.77","article-title":"Structural and functional analysis of hypoxia-inducible factor 1","volume":"51","author":"Semenza","year":"1997","journal-title":"Kidney Int"},{"key":"10.1016\/j.bcp.2010.02.017_bib65","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1002\/art.24851","volume":"60","author":"Duval","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bcp.2010.02.017_bib66","doi-asserted-by":"crossref","first-page":"R904","DOI":"10.1186\/ar1765","article-title":"Catabolic stress induces expression of hypoxia-inducible factor (HIF)-1alpha in articular chondrocytes: involvement of HIF-1alpha in the pathogenesis of osteoarthritis","volume":"7","author":"Yudoh","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.bcp.2010.02.017_bib67","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1073\/pnas.0708474105","article-title":"Activation of the hypoxia-inducible factor-1alpha pathway accelerates bone regeneration","volume":"105","author":"Wan","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2010.02.017_bib68","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.2174\/1381612033453749","article-title":"Anti-inflammatory actions of the heme oxygenase-1 pathway","volume":"9","author":"Alcaraz","year":"2003","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.bcp.2010.02.017_bib69","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/S0006-2952(03)00543-4","article-title":"Expression of heme oxygenase-1 and regulation by cytokines in human osteoarthritic chondrocytes","volume":"66","author":"Fernandez","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2010.02.017_bib70","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/path.2313","article-title":"Heme oxygenase-1 regulates catabolic and anabolic processes in osteoarthritic chondrocytes","volume":"214","author":"Guillen","year":"2008","journal-title":"J Pathol"},{"key":"10.1016\/j.bcp.2010.02.017_bib71","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1124\/jpet.107.134650","article-title":"The CO-releasing molecule CORM-2 protects human osteoarthritic chondrocytes and cartilage from the catabolic actions of interleukin-1","volume":"325","author":"Megias","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2010.02.017_bib72","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1093\/rheumatology\/ken264","article-title":"The CO-releasing molecule CORM-2 is a novel regulator of the inflammatory process in osteoarthritic chondrocytes","volume":"47","author":"Guillen","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.bcp.2010.02.017_bib73","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1016\/j.bcp.2009.03.009","article-title":"Heme oxygenase-1 induction modulates microsomal prostaglandin E synthase-1 expression and prostaglandin E(2) production in osteoarthritic chondrocytes","volume":"77","author":"Megias","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2010.02.017_bib74","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.joca.2009.11.005","article-title":"MAPKs are essential upstream signaling pathways in proteolytic cartilage degradation \u2013 divergence in pathways leading to aggrecanase and MMP-mediated articular cartilage degradation","volume":"18","author":"Sondergaard","year":"2010","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.bcp.2010.02.017_bib75","first-page":"22","volume":"5","author":"Brown","year":"2008","journal-title":"P38 MAP kinase inhibitors as potential therapeutics for the treatment of joint degeneration and pain associated with osteoarthritis. J Inflamm (Lond)"},{"key":"10.1016\/j.bcp.2010.02.017_bib76","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1093\/rheumatology\/kel078","article-title":"Adenoviral gene transfer into osteoarthritis synovial cells using the endogenous inhibitor IkappaBalpha reveals that most, but not all, inflammatory and destructive mediators are NFkappaB dependent","volume":"45","author":"Amos","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.bcp.2010.02.017_bib77","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.joca.2007.06.006","article-title":"Suppression of early experimental osteoarthritis by in vivo delivery of the adenoviral vector-mediated NF-kappaBp65-specific siRNA","volume":"16","author":"Chen","year":"2008","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.bcp.2010.02.017_bib78","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1093\/rheumatology\/kel419","article-title":"Interleukin-1beta induced activation of nuclear factor-kappaB can be inhibited by novel pharmacological agents in osteoarthritis","volume":"46","author":"Lauder","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.bcp.2010.02.017_bib79","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11926-009-0004-6","article-title":"WNT Signaling in osteoarthritis and osteoporosis: what is the biological significance for the clinician?","volume":"11","author":"Lodewyckx","year":"2009","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.bcp.2010.02.017_bib80","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.joca.2006.07.004","article-title":"Alteration of matrix glycosaminoglycans diminishes articular chondrocytes\u2019 response to a canonical Wnt signal","volume":"15","author":"Shortkroff","year":"2007","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.bcp.2010.02.017_bib81","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/art.23444","article-title":"Identification of the molecular response of articular cartilage to injury by microarray screening: Wnt-16 expression and signaling after injury and in osteoarthritis","volume":"58","author":"Dell\u2019Accio","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bcp.2010.02.017_bib82","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/art.24247","article-title":"Involvement of the Wnt signaling pathway in experimental and human osteoarthritis: prominent role of Wnt-induced signaling protein 1","volume":"60","author":"Blom","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bcp.2010.02.017_bib83","doi-asserted-by":"crossref","first-page":"16817","DOI":"10.1073\/pnas.0904414106","article-title":"Chromatin protein HMGB2 regulates articular cartilage surface maintenance via beta-catenin pathway","volume":"106","author":"Taniguchi","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2010.02.017_bib84","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1002\/art.23137","article-title":"Articular cartilage and biomechanical properties of the long bones in Frzb-knockout mice","volume":"56","author":"Lories","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bcp.2010.02.017_bib85","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1002\/art.22867","article-title":"Wnt signaling antagonists are potential prognostic biomarkers for the progression of radiographic hip osteoarthritis in elderly Caucasian women","volume":"56","author":"Lane","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bcp.2010.02.017_bib86","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nm1538","article-title":"Dickkopf-1 is a master regulator of joint remodeling","volume":"13","author":"Diarra","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.bcp.2010.02.017_bib87","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1002\/art.23614","article-title":"Inhibition of beta-catenin signaling in articular chondrocytes results in articular cartilage destruction","volume":"58","author":"Zhu","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bcp.2010.02.017_bib88","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/nature08356","article-title":"Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling","volume":"461","author":"Huang","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2010.02.017_bib89","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.bmcl.2009.10.093","article-title":"Hit to lead studies on (hetero)arylpyrimidines-Agonists of the canonical Wnt-beta-catenin cellular messaging system","volume":"20","author":"Gilbert","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bcp.2010.02.017_bib90","doi-asserted-by":"crossref","first-page":"6962","DOI":"10.1021\/jm9014197","article-title":"(1-(4-(Naphthalen-2-yl)pyrimidin-2-yl)piperidin-4-yl)methanamine: a wingless beta-catenin agonist that increases bone formation rate","volume":"52","author":"Pelletier","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.bcp.2010.02.017_bib91","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1002\/art.22041","article-title":"Contribution of runt-related transcription factor 2 to the pathogenesis of osteoarthritis in mice after induction of knee joint instability","volume":"54","author":"Kamekura","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bcp.2010.02.017_bib92","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/nm.2055","article-title":"Modulating hedgehog signaling can attenuate the severity of osteoarthritis","volume":"15","author":"Lin","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.bcp.2010.02.017_bib93","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.joca.2006.07.002","article-title":"DNA methylation in osteoarthritic chondrocytes: a new molecular target","volume":"15","author":"Roach","year":"2007","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.bcp.2010.02.017_bib94","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/jor.20799","article-title":"Cellular and epigenetic features of a young healthy and a young osteoarthritic cartilage compared with aged control and OA cartilage","volume":"27","author":"da Silva","year":"2009","journal-title":"J Orthop Res"},{"key":"10.1016\/j.bcp.2010.02.017_bib95","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1002\/art.21300","article-title":"Association between the abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regions","volume":"52","author":"Roach","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bcp.2010.02.017_bib96","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1136\/ard.2007.069377","article-title":"Epigenetic regulation of leptin affects MMP-13 expression in osteoarthritic chondrocytes: possible molecular target for osteoarthritis therapeutic intervention","volume":"66","author":"Iliopoulos","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.bcp.2010.02.017_bib97","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/08977190802625179","article-title":"Inhibition of histone deacetylases antagonized FGF-2 and IL-1beta effects on MMP expression in human articular chondrocytes","volume":"27","author":"Wang","year":"2009","journal-title":"Growth Factors"},{"key":"10.1016\/j.bcp.2010.02.017_bib98","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/1471-2474-10-148","article-title":"Regulation of the IGFBP-5 and MMP-13 genes by the microRNAs miR-140 and miR-27a in human osteoarthritic chondrocytes","volume":"10","author":"Tardif","year":"2009","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.bcp.2010.02.017_bib99","doi-asserted-by":"crossref","first-page":"e3740","DOI":"10.1371\/journal.pone.0003740","article-title":"Integrative microRNA and proteomic approaches identify novel osteoarthritis genes and their collaborative metabolic and inflammatory networks","volume":"3","author":"Iliopoulos","year":"2008","journal-title":"PLoS ONE"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295210001590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295210001590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:00:19Z","timestamp":1762095619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295210001590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":99,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0006295210001590"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2010.02.017","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New molecular targets for the treatment of osteoarthritis","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2010.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}